Efficacy and Safety of Faster-acting Insulin Aspart Compared to NovoRapid® Both in Combination With Insulin Degludec in Children and Adolescents With Type 1 Diabetes
Public ClinicalTrials.gov record NCT02670915. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This trial is conducted globally. The aim of the trial is to investigate efficacy and safety of faster-acting insulin aspart compared to NovoRapid® both in combination with insulin degludec in children and adolescents with type 1 diabetes.
Study identification
- NCT ID
- NCT02670915
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 834 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 1 Year to 17 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 4, 2016 (Actual)
- Primary completion
- Feb 5, 2018 (Actual)
- Completion
- Mar 3, 2018 (Actual)
- Last update posted
- Jun 5, 2019
2016 – 2018
United States locations
- U.S. sites
- 38
- U.S. states
- 22
- U.S. cities
- 35
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Novo Nordisk Investigational Site | Phoenix | Arizona | 85053 | — |
| Novo Nordisk Investigational Site | Tucson | Arizona | 85724 | — |
| Novo Nordisk Investigational Site | Long Beach | California | 90806 | — |
| Novo Nordisk Investigational Site | Los Angeles | California | 90027 | — |
| Novo Nordisk Investigational Site | Sacramento | California | 95821 | — |
| Novo Nordisk Investigational Site | Ventura | California | 93003 | — |
| Novo Nordisk Investigational Site | Aurora | Colorado | 80045 | — |
| Novo Nordisk Investigational Site | Gainesville | Florida | 32608 | — |
| Novo Nordisk Investigational Site | Jacksonville | Florida | 32207 | — |
| Novo Nordisk Investigational Site | Orlando | Florida | 32806 | — |
| Novo Nordisk Investigational Site | Tallahassee | Florida | 32308 | — |
| Novo Nordisk Investigational Site | Tampa | Florida | 33612 | — |
| Novo Nordisk Investigational Site | Atlanta | Georgia | 30339 | — |
| Novo Nordisk Investigational Site | Boise | Idaho | 83712 | — |
| Novo Nordisk Investigational Site | Idaho Falls | Idaho | 83404-7596 | — |
| Novo Nordisk Investigational Site | Springfield | Illinois | 62702 | — |
| Novo Nordisk Investigational Site | Lexington | Kentucky | 40503 | — |
| Novo Nordisk Investigational Site | Baltimore | Maryland | 21229 | — |
| Novo Nordisk Investigational Site | Boston | Massachusetts | 02215 | — |
| Novo Nordisk Investigational Site | Minneapolis | Minnesota | 55416 | — |
| Novo Nordisk Investigational Site | Minneapolis | Minnesota | 55455 | — |
| Novo Nordisk Investigational Site | Las Vegas | Nevada | 89128 | — |
| Novo Nordisk Investigational Site | Neptune City | New Jersey | 07753 | — |
| Novo Nordisk Investigational Site | Buffalo | New York | 14203 | — |
| Novo Nordisk Investigational Site | Mineola | New York | 11501 | — |
| Novo Nordisk Investigational Site | Raleigh | North Carolina | 27610 | — |
| Novo Nordisk Investigational Site | Fargo | North Dakota | 58122 | — |
| Novo Nordisk Investigational Site | Columbus | Ohio | 43205 | — |
| Novo Nordisk Investigational Site | Tulsa | Oklahoma | 74135 | — |
| Novo Nordisk Investigational Site | Philadelphia | Pennsylvania | 19104 | — |
| Novo Nordisk Investigational Site | Philadelphia | Pennsylvania | 19107 | — |
| Novo Nordisk Investigational Site | Pittsburgh | Pennsylvania | 15224 | — |
| Novo Nordisk Investigational Site | Sioux Falls | South Dakota | 57105 | — |
| Novo Nordisk Investigational Site | Amarillo | Texas | 79106 | — |
| Novo Nordisk Investigational Site | Austin | Texas | 78731 | — |
| Novo Nordisk Investigational Site | Dallas | Texas | 75231 | — |
| Novo Nordisk Investigational Site | Dallas | Texas | 75235 | — |
| Novo Nordisk Investigational Site | Salt Lake City | Utah | 84132 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 117 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02670915, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 5, 2019 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02670915 live on ClinicalTrials.gov.